About 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid
3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid (PubChem CID 145010646) has the molecular formula C35H26ClFN5O3+
and a molecular weight of 619.08 g/mol. Its IUPAC name is 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid.
Molecular Properties
| Compound Name | 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid |
| PubChem CID | 145010646 |
| Molecular Formula | C35H26ClFN5O3+ |
| Molecular Weight | 619.08 g/mol |
| Exact Mass | 618.17 |
| IUPAC Name | 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid |
| SMILES | CO[n+]1cc(-c2cc(Cl)ccc2-n2cnnn2)ccc1C1(c2cc(F)cc(-c3cccc(C(=O)O)c3)c2)C[C@H]1c1ccccc1 |
| InChI | InChI=1S/C35H25ClFN5O3/c1-45-42-20-25(30-18-28(36)11-12-32(30)41-21-38-39-40-41)10-13-33(42)35(19-31(35)22-6-3-2-4-7-22)27-15-26(16-29(37)17-27)23-8-5-9-24(14-23)34(43)44/h2-18,20-21,31H,19H2,1H3/p+1/t31-,35?/m0/s1 |
| InChIKey | ZOINPYGGZKHUOE-MWGAKABSSA-O |
| XLogP | 6.31 |
| TPSA | 94.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 45 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 619.08 |
| LogP ≤ 5 | 6.31 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Analyze 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid?
The IUPAC name of 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid (CID 145010646) is 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid.
What is the SMILES notation for 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid?
The canonical SMILES for 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid is CO[n+]1cc(-c2cc(Cl)ccc2-n2cnnn2)ccc1C1(c2cc(F)cc(-c3cccc(C(=O)O)c3)c2)C[C@H]1c1ccccc1.
What is the InChIKey of 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid?
The InChIKey is ZOINPYGGZKHUOE-MWGAKABSSA-O. The full InChI is InChI=1S/C35H25ClFN5O3/c1-45-42-20-25(30-18-28(36)11-12-32(30)41-21-38-39-40-41)10-13-33(42)35(19-31(35)22-6-3-2-4-7-22)27-15-26(16-29(37)17-27)23-8-5-9-24(14-23)34(43)44/h2-18,20-21,31H,19H2,1H3/p+1/t31-,35?/m0/s1.
What are the key properties of 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid?
3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid has a molecular weight of 619.08 g/mol, XLogP of 6.31, 8 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[3-[(2S)-1-[5-[5-chloro-2-(tetrazol-1-yl)phenyl]-1-methoxypyridin-1-ium-2-yl]-2-phenylcyclopropyl]-5-fluorophenyl]benzoic acid is sourced from PubChem (CID 145010646), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).